Cited by 879Cancer-related Molecular PathwaysCervical Cancer and HPV ResearchUbiquitin and proteasome pathways

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

Open access

Huibregtse, J.M., Scheffner, M., Howley, P.M.·1991·The EMBO Journal

DOI 10.1002/j.1460-2075.1991.tb04990.xPMC PMC453163

Open this paper in CoChat — free account

Abstract

The E6 protein of human papillomavirus types 16 and 18 (HPV-16 and HPV-18) can stably associate with the p53 protein in vitro. In the presence of rabbit reticulocyte lysate, this association leads to the specific degradation of p53 through the ubiquitin-dependent proteolysis system. We have examined the E6-p53 complex in more detail and have found that association of E6 with p53 is mediated by an additional cellular factor. This factor is present in rabbit reticulocyte lysate, primary human keratinocytes and in each of five human cell lines examined. The factor is designated E6-AP, for E6-associated protein, based on the observation that the E6 proteins of HPV-16 and 18 can form a stable complex with the factor in the absence of p53, whereas p53 association with the factor can be detected only in the presence of E6. Gel filtration and coprecipitation experiments indicate that E6-AP is a monomeric protein of approximately 100 kDa.

Integrity signals

Registry

Crossref · 10.1002/j.1460-2075.1991.tb04990.x

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Self-citation
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Self-citation
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Self-citation
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Cyclin is degraded by the ubiquitin pathway
Glotzer, M., Murray, A. W., & Kirschner, M. W. (1991) · Nature · doi:10.1038/349132a0 · Cited by 2,359
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403

Show all 46 references

Sorted by citations

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,416
Self-citation
Human papillomavirus oncoproteins: pathways to transformation
Moody, C. A., & Laimins, L. A. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2886 · Cited by 1,814
UBIQUITIN-DEPENDENT PROTEIN DEGRADATION
Hochstrasser, M. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.405 · Cited by 1,706
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade
Scheffner, M., Nuber, U. A., & Huibregtse, J. M. (1995) · Nature · doi:10.1038/373081a0 · Cited by 1,017
Self-citation
A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase.
Huibregtse, J. M., Scheffner, M., Beaudenon, S. L., & Howley, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2563 · Cited by 1,011
Self-citation
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management
Lechner, M., Liu, J., Masterson, L. M., & Fenton, T. R. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00603-7 · Cited by 1,049
De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome
Matsuura, T., Sutcliffe, J. S., Fang, P., Galjaard, R. H., Jiang, Y., Benton, C. S., Rommens, J. M., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0197-74 · Cited by 858
Mutation of the Angelman Ubiquitin Ligase in Mice Causes Increased Cytoplasmic p53 and Deficits of Contextual Learning and Long-Term Potentiation
Jiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 841
A Proteolytic Pathway That Recognizes Ubiquitin as a Degradation Signal
Johnson, E. S., Philip, C. M., Ota, I. M., & Varshavsky, A. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17442 · Cited by 830
Human papillomavirus immortalization and transformation functions
Münger, K., & Howley, P. M. (2002) · Virus Research · doi:10.1016/s0168-1702(02)00190-9 · Cited by 768
Self-citation
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
Pathogenesis of Human Papillomaviruses in Differentiating Epithelia
Longworth, M. S., & Laimins, L. A. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.2.362-372.2004 · Cited by 680
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3.
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 666
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Yuan, J., Luo, K., Zhang, L., Cheville, J. C., & Lou, Z. (2010) · Cell · doi:10.1016/j.cell.2009.12.032 · Cited by 637
GENOMIC IMPRINTING IN MAMMALS
Bartolomei, M. S., & Tilghman, S. M. (1997) · Annual Review of Genetics · doi:10.1146/annurev.genet.31.1.493 · Cited by 633
Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activityPreprint
Ronco, L. V., Karpova, A. Y., Vidal, M., & Howley, P. M. (1998) · Genes & Development · doi:10.1101/gad.12.13.2061 · Cited by 631
Self-citation
Drug discovery in the ubiquitin–proteasome system
Nalepa, G., Rolfe, M., & Harper, J. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2056 · Cited by 635
The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation
Lonard, D. M., Nawaz, Z., Smith, C. L., & O’Malley, B. W. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80259-2 · Cited by 559
Cloning and Expression of the cDNA for E6-AP, a Protein that Mediates the Interaction of the Human Papillomavirus E6 Oncoprotein with p53
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.775 · Cited by 553
Self-citation
THE UBIQUITIN-CONJUGATION SYSTEM
Jentsch, S. (1992) · Annual Review of Genetics · doi:10.1146/annurev.ge.26.120192.001143 · Cited by 564
The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development
Bernassola, F., Karin, M., Ciechanover, A., & Melino, G. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.001 · Cited by 541
The Human Papillomavirus E6 protein and its contribution to malignant progression
Mantovani, F., & Banks, L. (2001) · Oncogene · doi:10.1038/sj.onc.1204869 · Cited by 519
Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein
Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T., & Ishibashi, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11612 · Cited by 474
The role of the E6-p53 interaction in the molecular pathogenesis of HPV
Thomas, M., Pim, D., & Banks, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202953 · Cited by 448
The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily
Nawaz, Z., Lonard, D. M., Smith, C. L., Lev-Lehman, E., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1182 · Cited by 455
The ubiquitin‐proteasome pathway and proteasome inhibitors
Myung, J., Kim, K. B., & Crews, C. M. (2001) · Medicinal Research Reviews · doi:10.1002/med.1009 · Cited by 453
Regulation of Transcription Factor YY1 by Acetylation and Deacetylation
Yao, Y., Yang, W., & Seto, E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5979-5991.2001 · Cited by 439
The E6 protein of human papillomavirus type 16 binds to and inhibits co‐activation by CBP and p300
Patel, D., Huang, S., Baglia, L. A., & McCance, D. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5061 · Cited by 439
The V Protein of Simian Virus 5 Inhibits Interferon Signalling by Targeting STAT1 for Proteasome-Mediated Degradation
Didcock, L., Young, D. F., Goodbourn, S., & Randall, R. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9928-9933.1999 · Cited by 422
Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications
Chung, C. H., & Gillison, M. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0784 · Cited by 417
The human papillomavirus family and its role in carcinogenesis
Tommasino, M. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.11.002 · Cited by 429
Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity
Hebner, C. M., & Laimins, L. A. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.488 · Cited by 400
Angelman syndrome — insights into a rare neurogenetic disorder
Buiting, K., Williams, C. A., & Horsthemke, B. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.133 · Cited by 414
Localization of the E6-AP Regions That Direct Human Papillomavirus E6 Binding, Association with p53, and Ubiquitination of Associated Proteins
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4918 · Cited by 395
Self-citation
Human papillomaviruses: diversity, infection and host interactions
McBride, A. A. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00617-5 · Cited by 372
Natural Product-Like Macrocyclic N-Methyl-Peptide Inhibitors against a Ubiquitin Ligase Uncovered from a Ribosome-Expressed De Novo Library
Yamagishi, Y., Shoji, I., Miyagawa, S., Kawakami, T., Katoh, T., Goto, Y., & Suga, H. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.09.013 · Cited by 352
Papillomavirus E6 oncoproteins
Pol, S. V., & Klingelhutz, A. J. (2013) · Virology · doi:10.1016/j.virol.2013.04.026 · Cited by 369
JNK targets p53 ubiquitination and degradation in nonstressed cellsPreprint
Fuchs, S. Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S. N., & Ronai, Z. A. (1998) · Genes & Development · doi:10.1101/gad.12.17.2658 · Cited by 338
Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells
Martínez, I., Gardiner, A. S., K F Board, Monzon, F. A., Edwards, R. P., & Khan, S. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210919 · Cited by 344
The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300
Zimmermann, H., Degenkolbe, R., Bernard, H., & O’Connor, M. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6209-6219.1999 · Cited by 338
Papillomavirus E6 proteins
Howie, H. L., Katzenellenbogen, R. A., & Galloway, D. A. (2008) · Virology · doi:10.1016/j.virol.2008.11.017 · Cited by 332
Oncogenic activities of human papillomaviruses
McLaughlin-Drubin, M. E., & Münger, K. (2009) · Virus Research · doi:10.1016/j.virusres.2009.06.008 · Cited by 332
The biological properties of E6 and E7 oncoproteins from human papillomaviruses
Ghittoni, R., Accardi, R., Hasan, U. A., Gheit, T., Sylla, B. S., & Tommasino, M. (2009) · Virus Genes · doi:10.1007/s11262-009-0412-8 · Cited by 335
Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1
Asher, G., Lotem, J., Cohen, B., Sachs, L., & Shaul, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1188 · Cited by 317
Physiological functions of imprinted genes
Tycko, B., & Morison, I. M. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10129 · Cited by 316
Ubiquitination of p53 and p21 Is Differentially Affected by Ionizing and UV Radiation
Maki, C. G., & Howley, P. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.355 · Cited by 308
Self-citation
COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective
Harris, C. C. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1187 · Cited by 291
Microarray Analysis Identifies Interferon-Inducible Genes and Stat-1 as Major Transcriptional Targets of Human Papillomavirus Type 31
Chang, Y. E., & Laimins, L. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4174-4182.2000 · Cited by 284
Transcriptional Activation of the Telomerase hTERT Gene by Human Papillomavirus Type 16 E6 Oncoprotein
Veldman, T., Horikawa, I., Barrett, J. C., & Schlegel, R. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4467-4472.2001 · Cited by 286
High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis
Yeo-Teh, N. S. L., Ito, Y., & Jha, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061706 · Cited by 291
Interaction of Papillomavirus E6 Oncoproteins with a Putative Calcium-Binding Protein
Chen, J. J., Reid, C. E., Band, V., & Androphy, E. J. (1995) · Science · doi:10.1126/science.7624774 · Cited by 275
Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a
Yamasaki, K. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg106 · Cited by 273
Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53‐mediated repression of transcription.
Lechner, M. S., Mack, D. H., Finicle, A. B., Crook, T., Vousden, K. H., & Laimins, L. A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05375.x · Cited by 272
Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene
Herber, R., Liem, A., Pitot, H. C., & Lambert, P. F. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1873-1881.1996 · Cited by 269
Derangements of Hippocampal Calcium/Calmodulin-Dependent Protein Kinase II in a Mouse Model for Angelman Mental Retardation Syndrome
Weeber, E. J., Jiang, Y., Elgersma, Y., Varga, A. W., Carrasquillo, Y., Brown, S. E., Christian, J. M., Mirnikjoo, B., Silva, A. J., Beaudet, A. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02634.2003 · Cited by 262
Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes
Mabb, A. M., Judson, M. C., Zylka, M. J., & Philpot, B. D. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.04.001 · Cited by 263
The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative Cells
Talis, A. L., Huibregtse, J. M., & Howley, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6439 · Cited by 261
Self-citation
Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53.
Scheffner, M., Huibregtse, J. M., & Howley, P. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8797 · Cited by 260
Self-citation
Biology of human papillomaviruses
McMurray, H. R., Nguyen, D. X., Westbrook, T. F., & McCance, D. J. (2001) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2001.00177.x · Cited by 254
The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.Preprint
Maheswaran, S., Englert, C., Bennett, P., Heinrich, G., & Haber, D. A. (1995) · Genes & Development · doi:10.1101/gad.9.17.2143 · Cited by 248
Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter
Veldman, T., Liu, X., Yuan, H., & Schlegel, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1435900100 · Cited by 251
Telomerase Activation by Human Papillomavirus Type 16 E6 Protein: Induction of Human Telomerase Reverse Transcriptase Expression through Myc and GC-Rich Sp1 Binding Sites
Oh, S. T., Kyo, S., & Laimins, L. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5559-5566.2001 · Cited by 243
HPV-DNA Integration and Carcinogenesis: Putative Roles For Inflammation And Oxidative Stress
Williams, V. M., Filippova, M., Soto, U., & Duerksen-Hughes, P. J. (2010) · Future Virology · doi:10.2217/fvl.10.73 · Cited by 255
Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101.
Klencke, B. J., Matijevic, M., Urban, R. G., Lathey, J. L., Hedley, M. L., Berry, M. J., Thatcher, J., Weinberg, V., Wilson, J., Darragh, T. M., et al. (2002) · PubMed · Cited by 230
The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation
Scarth, J. A., Patterson, M. R., Morgan, E. L., & Macdonald, A. (2021) · Journal of General Virology · doi:10.1099/jgv.0.001540 · Cited by 237
Inhibition of p53 DNA binding by human papillomavirus E6 proteins
Lechner, M. S., & Laimins, L. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4262-4273.1994 · Cited by 238
The PDZ Ligand Domain of the Human Papillomavirus Type 16 E6 Protein Is Required for E6's Induction of Epithelial Hyperplasia In Vivo
Nguyen, M. L., Nguyen, M. M., Lee, D., Griep, A. E., & Lambert, P. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6957-6964.2003 · Cited by 230
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1
Asher, G., Lotem, J., Sachs, L., Kahana, C., & Shaul, Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202480499 · Cited by 223
Structural Basis for Hijacking of Cellular LxxLL Motifs by Papillomavirus E6 Oncoproteins
Zanier, K., Charbonnier, S., Sidi, A. O. M. O., McEwen, A. G., Ferrario, M. G., Poussin‐Courmontagne, P., Cura, V., Brimer, N., Babah, K. O., Ansari, T., et al. (2013) · Science · doi:10.1126/science.1229934 · Cited by 231
Interaction of p53 with the Human Rad51 Protein
Buchhop, S., Gibson, M. K., Wang, X. W., Wagner, P., Stürzbecher, H.-W., & Harris, C. C. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.19.3868 · Cited by 212
Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer
Lõhmussaar, K., Oka, R., Espejo Valle-Inclan, J., Smits, M. H. H., Wardak, H., Korving, J., Begthel, H., Proost, N., van de Ven, M., Kranenburg, O. W., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.03.012 · Cited by 211
Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types.
Thomas, M., & Banks, L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-6-1513 · Cited by 211
The role of human papillomavirus in nongenital cancers
Zandberg, D. P., Bhargava, R. S., Badin, S., & Cullen, K. J. (2012) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21167 · Cited by 209
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
Hengstermann, A., Linares, L. K., Ciechanover, A. J., Whitaker, N. J., & Scheffner, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1218 · Cited by 212
Self-citation
The role of TP53 in Cervical carcinogenesis
Tommasino, M., Accardi, R., Caldeira, S., Dong, W., Malanchi, I., Smet, A., & Zehbe, I. (2003) · Human Mutation · doi:10.1002/humu.10178 · Cited by 207
Identification of HHR23A as a Substrate for E6-associated Protein-mediated Ubiquitination
Kumar, S., Talis, A. L., & Howley, P. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18785 · Cited by 206
Self-citation
Human Papillomavirus Type 31 E5 Protein Supports Cell Cycle Progression and Activates Late Viral Functions upon Epithelial Differentiation
Fehrmann, F., Klumpp, D. J., & Laimins, L. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.5.2819-2831.2003 · Cited by 202
Chasing molecular glue degraders: screening approaches
Domostegui, A., Nieto-Barrado, L., Perez-Lopez, C., & Mayor-Ruiz, C. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00197g · Cited by 200
High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation
Li, X., & Coffino, P. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4509-4516.1996 · Cited by 200
E6 Oncoprotein Represses p53-Dependent Gene Activation via Inhibition of Protein Acetylation Independently of Inducing p53 Degradation
Thomas, M. C., & Chiang, C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.016 · Cited by 198
Genetics of Angelman Syndrome
Jiang, Y.-H., Lev-Lehman, E., Bressler, J., Tsai, T., & Beaudet, A. L. (1999) · The American Journal of Human Genetics · doi:10.1086/302473 · Cited by 205
Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes
Thomas, J. T., Hubert, W. G., Ruesch, M. N., & Laimins, L. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8449 · Cited by 199
Comprehensive Analysis of Host Cellular Interactions with Human Papillomavirus E6 Proteins Identifies New E6 Binding Partners and Reflects Viral Diversity
White, E. A., Kramer, R. E., Tan, M. J. A., Hayes, S. D., Harper, J. W., & Howley, P. M. (2012) · Journal of Virology · doi:10.1128/jvi.02172-12 · Cited by 198
Self-citation
Multiple Functions of Human Papillomavirus Type 16 E6 Contribute to the Immortalization of Mammary Epithelial Cells
Liu, Y., Chen, J. J., Gao, Q., Dalal, S. N., Hong, Y., Mansur, C. P., Band, V., & Androphy, E. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7297-7307.1999 · Cited by 197
Human Papillomaviruses and Cervical Neoplasia: A Model for Carcinogenesis
Stoler, M. H. (2000) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200001000-00004 · Cited by 194
Hypoxia-Inducible Erythropoietin Signaling in Squamous Dysplasia and Squamous Cell Carcinoma of the Uterine Cervix and Its Potential Role in Cervical Carcinogenesis and Tumor Progression
Ács, G., Zhang, P. J., McGrath, C. M., Acs, P. I., McBroom, J. W., Mohyeldin, A., Liu, S., Lu, H., & Verma, A. M. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64314-3 · Cited by 194
Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73
Marín, M. C., Jost, C. A., Irwin, M. S., DeCaprio, J. A., Caput, D., & Kaelin, W. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6316 · Cited by 193
Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation
Mittal, S., & Banks, L. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.08.001 · Cited by 200
TAZ Promotes PC2 Degradation through a SCF β-Trcp E3 Ligase Complex
Tian, Y., Kolb, R. J., Hong, J.-H., Carroll, J., Li, D., You, J., Bronson, R. T., Yaffe, M. B., Zhou, J., & Benjamin, T. L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00254-07 · Cited by 199
RETRACTED ARTICLE: E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage
Jackson, S., & Storey, A. (2000) · Oncogene · doi:10.1038/sj.onc.1203339 · Cited by 190
Retracted
Human Papillomavirus Types 16 E6 and E7 Contribute Differently to Carcinogenesis
Song, S., Liem, A., Miller, J. A., & Lambert, P. F. (2000) · Virology · doi:10.1006/viro.1999.0106 · Cited by 187
The E6 Oncoproteins of High-Risk Papillomaviruses Bind to a Novel Putative GAP Protein, E6TP1, and Target It for Degradation
Gao, Q., Srinivasan, S. V., Boyer, S. N., Wazer, D. E., & Band, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.733 · Cited by 187
The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest
Foster, S. A., Demers, G. W., Etscheid, B. G., & Galloway, D. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5698-5705.1994 · Cited by 185
E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c- myc
Gewin, L. C., & Galloway, D. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7198-7201.2001 · Cited by 184
Targeting Persistent Human Papillomavirus Infection
Shanmugasundaram, S., & You, J. (2017) · Viruses · doi:10.3390/v9080229 · Cited by 184
Two Domains of p53 Interact with the TATA-Binding Protein, and the Adenovirus 13S E1A Protein Disrupts the Association, Relieving p53-Mediated Transcriptional Repression
Horikoshi, N., Usheva, A., Chen, J., Levine, A. J., Weinmann, R. S., & Shenk, T. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.227 · Cited by 182
Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein
Jones, D. L., & Münger, K. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2905-2912.1997 · Cited by 178
The ubiquitin system, disease, and drug discovery
Petroski, M. D. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s7 · Cited by 184

Authors: Huibregtse, J. M., Scheffner, M., & Howley, P. M.
Affiliations: National Institutes of Health (US)
ORCID: Huibregtse, J.M.
Scheffner, M.
Howley, P.M.
Venue: The EMBO Journal
Publisher: Springer Science and Business Media LLC
Published: 1991-12-01
Volume: 10
Issue: 13
Pages: 4129-4135
ISSN: 0261-4189 (ISSN-L)
1460-2075
DOI: 10.1002/j.1460-2075.1991.tb04990.x
PMC: PMC453163
OpenAlex: W140061535
Cited by: 879
References: 46
Citations by year: 2026: 8 · 2025: 15 · 2024: 16 · 2023: 26 · 2022: 21 · 2021: 25 · 2020: 27 · 2019: 18 · 2018: 28 · 2017: 29 · 2016: 19 · 2015: 26 · 2014: 29 · 2013: 28 · 2012: 41
FWCI: 5.96
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: The EMBO Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Forschungsgemeinschaft
National Cancer Institute
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords: p53, E6 oncoprotein, HPV16, HPV 18, UBE3A, ubiquitin-mediated proteolysis, p53 degradation, protein-protein interaction, keratinocytes, tumor suppressor
MeSH terms: Animals, Cell Line, Chromatography, Gel, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Humans, Hydrolysis, Oncogene Proteins, Viral, Plasmids, Protein Binding, Proteins, Repressor Proteins, Reticulocytes, Tumor Suppressor Protein p53, Papillomaviridae

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks